Demographic data on the study patients
| Patient No./Age (y)/Sex | Pathologic Diagnosis (Grade of Gliomas, 1–4) | Diagnostic Method | rTPmax | mADC ×10−3 mm/s2 |
|---|---|---|---|---|
| 1/41/M | 2 | Biopsy | 1.01 | 0.92 |
| 2/51/M | 4 | Surgery | 1.55 | 0.89 |
| 3/29/M | 2 | Surgery | 1.05 | 1.23 |
| 4/30/F | 2 | Biopsy | 1.27 | 1.16 |
| 5/42/F | 4 | Surgery | 1.59 | 0.71 |
| 6/41/M | 3 | Surgery | 1.29 | 0.98 |
| 7/45/M | 4 | Biopsy | 1.62 | 0.43 |
| 8/43/F | 3 | Surgery | 1.32 | 0.68 |
| 9/30/F | 2 | Surgery | 0.97 | 0.94 |
| 10/32/M | 2 | Surgery | 1.13 | 1.24 |
| 11/35/F | 4 | Surgery | 2.25 | 0.92 |
| 12/41/F | 3 | Surgery | 1.23 | 0.78 |
| 13/42/M | 4 | Biopsy | 1.93 | 0.72 |
| 14/40/M | 3 | Surgery | 1.29 | 0.84 |
| 15/32/M | 2 | Surgery | 1.28 | 1.45 |
| 16/46/F | 4 | Surgery | 1.80 | 1.06 |
| 17/39/F | 4 | Surgery | 2.24 | 0.88 |
| 18/52/M | 3 | Biopsy | 1.29 | 0.87 |
| 19/42/M | 4 | Surgery | 1.43 | 0.74 |
| 20/35/F | 2 | Surgery | 0.89 | 1.22 |
| 21/39/M | 4 | Surgery | 1.56 | 0.76 |
| 22/30/F | 3 | Surgery | 1.26 | 0.78 |
| 23/40/F | 4 | Surgery | 1.43 | 0.59 |
| 24/42/M | 2 | Surgery | 1.24 | 1.15 |
| 25/52/M | 4 | Biopsy | 1.66 | 0.88 |
| 26/45/F | 3 | Biopsy | 1.26 | 0.69 |
| 27/42/M | 4 | Surgery | 1.29 | 0.69 |
| 28/37/F | 2 | Surgery | 1.11 | 1.28 |
| 29/50/M | 2 | Surgery | 1.01 | 1.01 |
| 30/51/M | 4 | Biopsy | 1.44 | 0.72 |
| 31/29/M | 2 | Surgery | 1.17 | 1.15 |
| 32/51/F | 4 | Surgery | 1.30 | 0.84 |
| 33/67/M | 4 | Surgery | 1.32 | 0.94 |
Note:—rTPmax indicates ratio of maximum tumor perfusion signal intensity; mADC, minimum apparent diffusion coefficient value.